These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 37085840)

  • 1. De novo variation in EP300 gene cause Rubinstein-Taybi syndrome 2 in a Chinese family with severe early-onset high myopia.
    Huang X; Rui X; Zhang S; Qi X; Rong W; Sheng X
    BMC Med Genomics; 2023 Apr; 16(1):84. PubMed ID: 37085840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: a Chinese girl like atypical Rubinstein-Taybi syndrome caused by a novel heterozygous mutation of the EP300 gene.
    Bai Z; Li G; Kong X
    BMC Med Genomics; 2023 Feb; 16(1):24. PubMed ID: 36797748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the clinical and genetic spectrum.
    López M; García-Oguiza A; Armstrong J; García-Cobaleda I; García-Miñaur S; Santos-Simarro F; Seidel V; Domínguez-Garrido E
    BMC Med Genet; 2018 Mar; 19(1):36. PubMed ID: 29506490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First case report of inherited Rubinstein-Taybi syndrome associated with a novel EP300 variant.
    López M; Seidel V; Santibáñez P; Cervera-Acedo C; Castro-de Castro P; Domínguez-Garrido E
    BMC Med Genet; 2016 Dec; 17(1):97. PubMed ID: 27964710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and clinical heterogeneity in Korean patients with Rubinstein-Taybi syndrome.
    Choi N; Kim HY; Lim BC; Chae JH; Kim SY; Ko JM
    Mol Genet Genomic Med; 2021 Oct; 9(10):e1791. PubMed ID: 34427995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo variation in ARID1B gene causes Coffin-Siris syndrome 1 in a Chinese family with excessive early-onset high myopia.
    Huang X; Li H; Yang S; Ma M; Lian Y; Wu X; Qi X; Wang X; Rong W; Sheng X
    BMC Med Genomics; 2024 May; 17(1):142. PubMed ID: 38790056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identical EP300 variant leading to Rubinstein-Taybi syndrome with different clinical and immunologic phenotype.
    Saettini F; Fazio G; Bonati MT; Moratto D; Massa V; Di Fede E; Castiglioni S; Marchetti D; Chiarini M; Sottini A; Iascone M; Cazzaniga G; Imberti L; Biondi A; Gervasini C; Badolato R
    Am J Med Genet A; 2022 Jul; 188(7):2129-2134. PubMed ID: 35266289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical exome sequencing identifies novel CREBBP variants in 18 Chinese Rubinstein-Taybi Syndrome kids with high frequency of polydactyly.
    Yu S; Wu B; Qian Y; Zhang P; Lu Y; Dong X; Wang Q; Zhao X; Liu R; Zhou W; Wang H
    Mol Genet Genomic Med; 2019 Dec; 7(12):e1009. PubMed ID: 31637876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rubinstein-Taybi syndrome in a Saudi boy with distinct features and variants in both the CREBBP and EP300 genes: a case report.
    Al-Qattan MM; Jarman A; Rafique A; Al-Hassnan ZN; Al-Qattan HM
    BMC Med Genet; 2019 Jan; 20(1):12. PubMed ID: 30635043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into genetic variant spectrum and genotype-phenotype correlations of Rubinstein-Taybi syndrome in 39 CREBBP-positive patients.
    Pérez-Grijalba V; García-Oguiza A; López M; Armstrong J; García-Miñaur S; Mesa-Latorre JM; O'Callaghan M; Pineda Marfa M; Ramos-Arroyo MA; Santos-Simarro F; Seidel V; Domínguez-Garrido E
    Mol Genet Genomic Med; 2019 Nov; 7(11):e972. PubMed ID: 31566936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel heterozygous variants in the EP300 gene cause Rubinstein-Taybi syndrome 2: Reports from two Chinese children.
    Du C; Li Z; Zou B; Li X; Chen F; Liang Y; Luo X; Shu S
    Mol Genet Genomic Med; 2023 Sep; 11(9):e2192. PubMed ID: 37162176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mutations of the X-linked genes associated with early-onset high myopia in five Chinese families.
    Zi F; Li Z; Cheng W; Huang X; Sheng X; Rong W
    BMC Med Genomics; 2023 Sep; 16(1):223. PubMed ID: 37749571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of de novo EP300 and PLAU variants in a patient with Rubinstein-Taybi syndrome-related arterial vasculopathy and skeletal anomaly.
    Park JE; Kim E; Lee DW; Park TK; Kim MS; Jang SY; Ahn J; Park KB; Kim KH; Park HC; Ki CS; Kim DK
    Sci Rep; 2021 Aug; 11(1):15931. PubMed ID: 34354133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperinsulinism in an individual with an EP300 variant of Rubinstein-Taybi syndrome.
    Wild KT; Nomakuchi TT; Sheppard SE; Leavens KF; De León DD; Zackai EH
    Am J Med Genet A; 2021 Apr; 185(4):1251-1255. PubMed ID: 33442921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring by whole exome sequencing patients with initial diagnosis of Rubinstein-Taybi syndrome: the interconnections of epigenetic machinery disorders.
    Negri G; Magini P; Milani D; Crippa M; Biamino E; Piccione M; Sotgiu S; Perrìa C; Vitiello G; Frontali M; Boni A; Di Fede E; Gandini MC; Colombo EA; Bamshad MJ; Nickerson DA; Smith JD; Loddo I; Finelli P; Seri M; Pippucci T; Larizza L; Gervasini C
    Hum Genet; 2019 Mar; 138(3):257-269. PubMed ID: 30806792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations.
    Fergelot P; Van Belzen M; Van Gils J; Afenjar A; Armour CM; Arveiler B; Beets L; Burglen L; Busa T; Collet M; Deforges J; de Vries BB; Dominguez Garrido E; Dorison N; Dupont J; Francannet C; Garciá-Minaúr S; Gabau Vila E; Gebre-Medhin S; Gener Querol B; Geneviève D; Gérard M; Gervasini CG; Goldenberg A; Josifova D; Lachlan K; Maas S; Maranda B; Moilanen JS; Nordgren A; Parent P; Rankin J; Reardon W; Rio M; Roume J; Shaw A; Smigiel R; Sojo A; Solomon B; Stembalska A; Stumpel C; Suarez F; Terhal P; Thomas S; Touraine R; Verloes A; Vincent-Delorme C; Wincent J; Peters DJ; Bartsch O; Larizza L; Lacombe D; Hennekam RC
    Am J Med Genet A; 2016 Dec; 170(12):3069-3082. PubMed ID: 27648933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From Whole Gene Deletion to Point Mutations of EP300-Positive Rubinstein-Taybi Patients: New Insights into the Mutational Spectrum and Peculiar Clinical Hallmarks.
    Negri G; Magini P; Milani D; Colapietro P; Rusconi D; Scarano E; Bonati MT; Priolo M; Crippa M; Mazzanti L; Wischmeijer A; Tamburrino F; Pippucci T; Finelli P; Larizza L; Gervasini C
    Hum Mutat; 2016 Feb; 37(2):175-83. PubMed ID: 26486927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent variant patterns among 19 patients with Rubinstein-Taybi syndrome uncovered by comprehensive genetic analysis including whole genome sequencing.
    Enomoto Y; Yokoi T; Tsurusaki Y; Murakami H; Tominaga M; Minatogawa M; Abe-Hatano C; Kuroda Y; Ohashi I; Ida K; Shiiya S; Kumaki T; Naruto T; Mitsui J; Harada N; Kido Y; Kurosawa K
    Clin Genet; 2022 Mar; 101(3):335-345. PubMed ID: 34958122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rubinstein-Taybi syndrome 2 with cerebellar abnormality and neural tube defect.
    Hadzsiev K; Gyorsok Z; Till A; Czakó M; Bartsch O
    Clin Dysmorphol; 2019 Jul; 28(3):137-141. PubMed ID: 30789376
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.